Morbidity and Mortality Weekly Reports
CDC’s Morbidity and Mortality Weekly Report publishes public health information and recommendations on a variety of diseases and topics. Read the most recent MMWRs on HIV.
With this form, you can search through all the Morbidity and Mortality Weekly Reports:
Recent HIV-Related Reports
HIV Testing, Linkage to HIV Medical Care, and Interviews for Partner Services Among Black Men Who Have Sex with Men — Non–Health Care Facilities, 20 Southern U.S. Jurisdictions, 2016
What is already known about this topic?
Black men who have sex with men (MSM) are disproportionately affected by human immunodeficiency virus (HIV) infection, accounting for 38% of all new HIV diagnoses among MSM in the United States in 2016.
What is added by this report?
Analysis of CDC-funded HIV testing for black MSM in 20 southern U.S. jurisdictions in 2016 revealed that black MSM received 6% of the HIV tests provided and accounted for 36% of the new HIV diagnoses in non–health care facilities.
Prevalence and Predictors of Provider-Initiated HIV Test Offers Among Heterosexual Persons at Increased Risk for Acquiring HIV Infection — Virginia, 2016
In a sample of 333 health care–seeking, heterosexual adults at increased risk for acquiring HIV infection, 194 (58%) reported not receiving an HIV test offer at a recent medical visit(s), and men (versus women) had a significantly lower prevalence of provider-initiated HIV test offers (32% versus 48%). Recent HIV testing was higher among recipients of provider-initiated offers compared with nonrecipients (71% versus 16%).
Interval Since Last HIV Test for Men and Women with Recent Risk for HIV Infection — United States, 2006–2016
Analysis of 2006–2016 national population-based data found that the percentage of persons ever tested and median interval since last test remained unchanged. The median interval since last test among persons with recent HIV risk was shorter than that of other persons tested but exceeded 1 year.
Peer-Delivered Linkage Case Management and Same-Day ART Initiation for Men and Young Persons with HIV Infection — Eswatini, 2015–2017
Among 651 persons diagnosed with HIV infection in community settings in Eswatini, 98% enrolled in care, and 83% initiated ART within a few days of receiving peer-delivered linkage case management services recommended by CDC and the World Health Organization. After expansion of ART eligibility for all persons with HIV infection, 96% initiated ART.
HIV Preexposure Prophylaxis in the U.S. Military Services — 2014–2016
Human immunodeficiency virus (HIV) infection is a substantial health concern for the U.S. Department of Defense (DoD) and for service members stationed throughout the world. Each year, approximately 350 new HIV infections are diagnosed in members of the U.S. military services, with most infections acquired within the United States. Among 769 service members prescribed preexposure prophylaxis (PrEP) during February 1, 2014–June 10, 2016, 87% were MSM. In a survey of health care providers, 49% rated their knowledge of PrEP as poor, and 29% reported ever having prescribed PrEP.
Trends in Antiretroviral Therapy Eligibility and Coverage Among Children Aged <15 Years with HIV Infection — 20 PEPFAR-Supported Sub-Saharan African Countries, 2012–2016
World Health Organization (WHO) guidelines have expanded the recommended criteria for life-saving antiretroviral therapy (ART) eligibility among children with human immunodeficiency virus (HIV) infection. All 20 sub-Saharan African countries included in this analysis adopted the 2013 WHO guidelines by 2015. In 2016, 13 of 20 countries adopted the 2016 guidelines to treat all children; however, approximately 56% of children aged <15 years with HIV infection in these countries were not receiving ART.
Access to Syringe Services Programs — Kentucky, North Carolina, and West Virginia, 2013–2017
The Appalachian region of the United States is experiencing a large increase in hepatitis C virus (HCV) infections related to injection drug use (IDU). Syringe services programs (SSPs) providing sufficient access to safe injection equipment can reduce hepatitis C transmission by 56%; combined SSPs and medication-assisted treatment can reduce transmission by 74%. However, access to SSPs has been limited in the United States, especially in rural areas and southern and midwestern states.
HIV Diagnoses Among Persons Aged 13–29 Years — United States, 2010–2014
HIV diagnoses analyzed by age groups revealed striking differences in rates of diagnosis of HIV infection between ages 13–21 years. During 2010–2014, HIV infection diagnosis rates per 100,000 population varied substantially with increasing age among persons aged 13–15 years (0.7), 16–17 years (4.5), 18–19 years (16.5), and 20–21 years (28.6). HIV diagnosis rates were higher, but less variable, among persons aged 22–23 years (34.0), 24–25 years (33.8), 26–27 years (31.3), and 28–29 years (28.7).
Racial and Ethnic Disparities in Sustained Viral Suppression and Transmission Risk Potential Among Persons Receiving HIV Care — United States, 2014
In 2014, fewer blacks living with diagnosed HIV infection had sustained viral suppression (all viral load test results in 2014 <200 HIV RNA copies/mL) compared with Hispanics and whites. Among those who were in care and did not achieve sustained viral suppression, blacks had viral loads >1,500 copies/mL for approximately half of the 12-month period in 2014; this circumstance can adversely affect their health outcomes and pose a risk for further transmission. Blacks aged 13–24 years had the lowest prevalence of sustained viral suppression.
Notes from the Field: Public Health Response to a Human Immunodeficiency Virus Outbreak Associated with Unsafe Injection Practices — Roka Commune, Cambodia, 2016
Cambodians receive 0.8–5.9 therapeutic injections per person per year, one of the highest reported rates worldwide. Appropriate medical injections and infusions can be health sustaining or lifesaving; however, improper administration can have detrimental health consequences, including infectious disease transmission. In 2000, it was estimated that worldwide, unsafe injection and waste disposal practices account for 260,000 new human immunodeficiency virus (HIV) infections annually.
HIV Infection and HIV-Associated Behaviors Among Persons Who Inject Drugs — 20 Cities, United States, 2015
In 2015, National HIV Behavioral Surveillance found a 7% prevalence of HIV infection among persons who inject drugs which was lower than in 2012 (11%). Among HIV-negative respondents, 27% reported sharing syringes and 67% reported having vaginal sex without a condom in the previous 12 months; only 52% received syringes from a syringe services program and 34% received all syringes from sterile sources. HIV infection prevalence was higher among blacks (11%) than whites (6%) but more white persons who inject drugs shared syringes (white: 39%; black: 17%) and injection equipment (white: 61%; black: 41%) in the previous 12 months.
Status of HIV Epidemic Control Among Adolescent Girls and Young Women Aged 15–24 Years — Seven African Countries, 2015–2017
Analysis of data from Population-based HIV Impact Assessment surveys conducted during 2015–2017 in seven countries in Eastern and Southern Africa found that the prevalence of HIV infection among adolescent girls and young women was 3.6%. Among those who were HIV-positive, 46.3% reported being aware of their status, and among those aware of their HIV-positive status, 85.5% reported current antiretroviral treatment (ART) use. Overall, viral load suppression among HIV-infected adolescent girls and young women, regardless of status awareness or current use of ART, was 45.0%, well below the UNAIDS target of 73%.
Scale-Up of Voluntary Medical Male Circumcision Services for HIV Prevention — 12 Countries in Southern and Eastern Africa, 2013–2016
Voluntary medical male circumcision (VMMC) has been recognized by the World Health Organization and Joint United Nations Programme on HIV/AIDS as an effective human immunodeficiency virus (HIV) infection prevention intervention in settings with a generalized HIV epidemic and low male circumcision prevalence. During 2010–2012, CDC (through the U.S. President’s Emergency Plan for AIDS Relief) supported 1,020,424 VMMCs in nine countries in Southern and Eastern Africa.
Vital Signs: Human Immunodeficiency Virus Testing and Diagnosis Delays — United States
Persons unaware of their human immunodeficiency virus (HIV) infection account for approximately 40% of ongoing transmissions in the United States. Persons are unaware of their infection because of delayed HIV diagnoses that represent substantial missed opportunities to improve health outcomes and prevent HIV transmission.
HIV Testing, Linkage to HIV Medical Care, and Interviews for Partner Services Among Women — 61 Health Department Jurisdictions, United States, Puerto Rico, and the U.S. Virgin Islands, 2015
Analysis of 2015 data on CDC-funded HIV tests and HIV prevention services from 61 health departments and 123 community-based organizations indicated that among women identified as having HIV infection, 62% had received a diagnosis of HIV infection before the current test, and 87% of those women were not in HIV medical care at the time of the test. Rates for linkage to medical care within 90 days of the current test date were 61% and 58% for women with newly diagnosed and previously diagnosed HIV infection, respectively. Among women with previously diagnosed HIV infection, 57% of black women and 65% of white women were linked to HIV medical care.
- Page last reviewed: June 28, 2018
- Page last updated: June 28, 2018
- Content source: Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention